Benefit of a pharmacist-led intervention for medication management of renal transplant patients: a controlled before-and-after study

por Chambord, Jeremy, Couzi, Lionel, Merville, Pierre, Moreau, Karine, Xuereb, Fabien, Djabarouti, Sarah
Publicado en Ther Adv Chronic Dis (2021)

Are Standard Dosing Regimens of Ceftriaxone Adapted for Critically Ill Patients with Augmented Creatinine Clearance?

por Ollivier, Julien, Carrié, Cédric, d’Houdain, Nicolas, Djabarouti, Sarah, Petit, Laurent, Xuereb, Fabien, Legeron, Rachel, Biais, Matthieu, Breilh, Dominique
Publicado en Antimicrob Agents Chemother (2019)

Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study

por Djabarouti, Sarah, Breilh, Dominique, Duffau, Pierre, Lazaro, Estibaliz, Greib, Carine, Caubet, Olivier, Saux, Marie-Claude, Pellegrin, Jean-Luc, Viallard, Jean-François
Publicado 2010

Correction: Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study

por Djabarouti, Sarah, Breilh, Dominique, Duffau, Pierre, Lazaro, Estibaliz, Greib, Carine, Caubet, Olivier, Saux, Marie-Claude, Pellegrin, Jean-Luc, Viallard, Jean-François
Publicado 2011

Pre-dose plasma concentration monitoring of mycophenolate mofetil in patients with autoimmune diseases

por Streicher, Caroline, Djabarouti, Sarah, Xuereb, Fabien, Lazaro, Estibaliz, Legeron, Rachel, Bouchet, Stéphane, Greib, Carine, Breilh, Dominique, Pellegrin, Jean-Luc, Viallard, Jean-François
Publicado en Br J Clin Pharmacol (2014)